# A Trial of Intravenous Denileukin Diftitox in Stage III or IV Ovarian Cancer

> **NCT00880360** · PHASE2 · COMPLETED · sponsor: **The University of Texas Health Science Center at San Antonio** · enrollment: 19 (actual)

## Conditions studied

- Epithelial Ovarian Cancer
- Extraovarian Peritoneal Cancer
- Fallopian Tube Carcinoma

## Interventions

- **DRUG:** Ontak

## Key facts

- **NCT ID:** NCT00880360
- **Lead sponsor:** The University of Texas Health Science Center at San Antonio
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2018-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00880360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00880360, "A Trial of Intravenous Denileukin Diftitox in Stage III or IV Ovarian Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00880360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*